Related Experiment Video
Updated: Mar 16, 2026
09:11
Zika Virus Infectious Cell Culture System and the In Vitro Prophylactic Effect of Interferons
Published on: August 23, 2016
21.6K
Summary
Zika virus, a flavivirus, causes mild illness in 20% of cases but can lead to severe neurological issues and congenital malformations. Prevention focuses on mosquito bite protection as no vaccine exists.
Area of Science:
- Virology
- Infectious Diseases
- Public Health
Context:
- Zika virus, a flavivirus, was first isolated in non-human primates in 1647 and subsequently in humans in 1954.
- The virus has seen significant global emergence, notably in Micronesia (2007), French Polynesia (2013-2014), South America (2015), and the French West Indies (2016).
- Transmission occurs through the bite of Aedes mosquitoes.
Purpose:
- To provide an overview of Zika virus epidemiology, clinical manifestations, diagnosis, and prevention.
- To highlight the neurological and congenital complications associated with Zika virus infection.
- To underscore the lack of specific treatments or vaccines.
Summary:
- Zika virus infection is often asymptomatic or presents as mild illness, affecting approximately 20% of infected individuals.
- Reported complications include neurological disorders such as Guillain-Barré syndrome and congenital malformations like microcephaly.
- Laboratory diagnosis relies on virus isolation via Polymerase Chain Reaction (PCR).
Impact:
- The emergence of Zika virus poses a significant public health threat due to its association with severe neurological and developmental outcomes.
- The absence of specific treatments and vaccines necessitates a strong focus on preventative measures, particularly mosquito bite protection.
- Understanding the transmission dynamics and clinical spectrum is crucial for effective disease surveillance and control strategies.
